EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of the American Academy of Dermatology

ISSN 0190-9622 · Elsevier BV

Latest articles

  1. Eosinophilic fasciitis induced by checkpoint inhibitors: A retrospective multicenter case series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review

    Quentin Riller, Loris Azoyan, Lucile Garrault, Léa Dousset, Elina Zuelgaray, Sorilla Mary-Prey, Ouidad Zehou, Carole Templier, Marie Guicheney, François Chasset, Lois Bolko, Isabelle Bourgault-Villada, Anne-Marie Roguedas-Contios, Cécile Lesort, Manuelle Viguier, Damien Sène, Maxime Battistella, Jean-David Bouaziz, Céleste Lebbe, Thibault Mahévas

    Published: 2026-11DOI: 10.1016/j.jaad.2026.07.001

  2. Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study

    Alan D. Irvine, Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Lisa A. Beck, Lawrence F. Eichenfield, Lisa Swanson, Sara C. Hamon, Julie E. Horowitz, Annamaria B. Farrell, Sarah Hatsell, Annie Zhang, Ashish Bansal, Xiaojun You, Zhen Chen, Stephane Levy, Sonya L. Cyr

    Published: 2026-11DOI: 10.1016/j.jaad.2026.07.006

Volumes

2026 · 3,7032025 · 2,7212024 · 2,5172023 · 2,0982022 · 2,0312021 · 2,0992020 · 2,0792019 · 2,0062018 · 1,9622017 · 1,9892016 · 1,8722015 · 1,8572014 · 1,6022013 · 1,7042012 · 1,6142011 · 1,5182010 · 1,2592009 · 1,4402008 · 1,3132007 · 1,5702006 · 8872005 · 1,7992004 · 1,5792003 · 7322002 · 5582001 · 5642000 · 7051999 · 5621998 · 5871997 · 6861996 · 7251995 · 7511994 · 6561993 · 6431992 · 6581991 · 7061990 · 7601989 · 7311988 · 6911987 · 820

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.